Orbimed Capital Gp Vii Llc
Director at Electra Therapeutics, Inc. (ETRA); Director at Q32 Bio Inc. (QTTB)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return+27.5%
vs. S&P 500+26.1%
Beat the market100%
Paper profit on buys−$7.3M
Total bought / sold$35.0M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 23SEC | ETRAElectra Therapeutics, Inc. | Buy | 333,3335,126,891 held (+7%) | $15.00 | $5.0M | -39.7% |
| Sep 23SEC | ETRAElectra Therapeutics, Inc. | Buy | 1,000,0001,758,279 held (+132%) | $15.00 | $15.0M | -39.7% |
| Jun 1SEC | QTTBQ32 Bio Inc. | Buy | 1,250,0003,502,987 held (+55%) | $8.00 | $10.0M | +4.2% |
| Jun 1SEC | QTTBQ32 Bio Inc. | Buy | 625,000new position | $8.00 | $5.0M | +4.2% |
- Buy
Director Orbimed Capital Gp Vii Llc bought $5.0M of ETRA at $15.00 — first open-market purchase in our records.
- Buy
Director Orbimed Capital Gp Vii Llc bought $15.0M of ETRA at $15.00 — largest purchase by this insider in our records; raises the stake by 132%.
- Buy
Director Orbimed Capital Gp Vii Llc bought $10.0M of QTTB at $8.00 — first open-market purchase in our records; raises the stake by 55%.
- Buy
Director Orbimed Capital Gp Vii Llc bought $5.0M of QTTB at $8.00 — opens a new position.